Peter Fröberg
Chief Tech/Sci/R&D Officer at SEDANA MEDICAL AB
Net worth: - $ as of 2024-04-29
Profile
Peter Fröberg currently works at Sedana Medical AB, as Chief Technology Officer from 2020.
Mr. Fröberg also formerly worked at Elekta Instruments AB, as Product Manager.
Mr. Fröberg received his graduate degree from Royal Institute of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SEDANA MEDICAL AB
-.--% | 2022-12-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Peter Fröberg active positions
Companies | Position | Start |
---|---|---|
SEDANA MEDICAL AB | Chief Tech/Sci/R&D Officer | 2020-10-31 |
Former positions of Peter Fröberg
Companies | Position | End |
---|---|---|
Elekta Instruments AB
Elekta Instruments AB Hospital/Nursing ManagementHealth Services Part of Elekta AB, Elekta Instruments AB provides brachytherapy treatment solutions for head and neck cancers, offering a wide array of applicators including the Rotterdam. The company is based in Stockholm, Sweden. The Swedish company's standalone or combination treatment, Elekta Esprit, is created with absolute expertise in mind, providing exceptional accuracy that spares healthy tissue in a seamless integrated system. The company helps clinicians treat cancer and brain disorders through precision radiation medicine, targeting the tumor and protecting the patient. Elekta has been providing innovative technologies to improve cancer care across the globe for 50 years. | Corporate Officer/Principal | - |
Training of Peter Fröberg
Royal Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SEDANA MEDICAL AB | Health Technology |
Private companies | 1 |
---|---|
Elekta Instruments AB
Elekta Instruments AB Hospital/Nursing ManagementHealth Services Part of Elekta AB, Elekta Instruments AB provides brachytherapy treatment solutions for head and neck cancers, offering a wide array of applicators including the Rotterdam. The company is based in Stockholm, Sweden. The Swedish company's standalone or combination treatment, Elekta Esprit, is created with absolute expertise in mind, providing exceptional accuracy that spares healthy tissue in a seamless integrated system. The company helps clinicians treat cancer and brain disorders through precision radiation medicine, targeting the tumor and protecting the patient. Elekta has been providing innovative technologies to improve cancer care across the globe for 50 years. | Health Services |
- Stock Market
- Insiders
- Peter Fröberg